GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MTNB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Matinas Biopharma Holdings Inc stock after losing 1.04%
(Updated on Apr 18, 2024)

Sell candidate since Apr 03, 2024 Loss -16.48% PDF

The Matinas Biopharma Holdings Inc stock price fell by -1.04% on the last day (Thursday, 18th Apr 2024) from $0.192 to $0.190. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 9.98% from a day low at $0.180 to a day high of $0.198. The price has fallen in 8 of the last 10 days and is down by -13.4% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -62 thousand shares and in total, 956 thousand shares were bought and sold for approximately $181.58 thousand.

Given the current short-term trend, the stock is expected to rise 12.55% during the next 3 months and, with a 90% probability hold a price between $0.214 and $0.426 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MTNB Signals & Forecast

There are few to no technical positive signals at the moment. The Matinas Biopharma Holdings Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.200 and $0.255. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -48.62%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Matinas Biopharma Holdings Inc stock

Matinas Biopharma Holdings Inc finds support from accumulated volume at $0.190 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0180 between high and low, or 9.98%. For the last week the stock has had daily average volatility of 6.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MTNB) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Matinas Biopharma Holdings Inc to open at $0.190, and during the day (based on 14 day Average True Range), to move between $0.163 and $0.217, which gives a possible trading interval of +/-$0.0273 (+/-14.38%) up or down from last closing price. If Matinas Biopharma Holdings Inc takes out the full calculated possible swing range there will be an estimated 28.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.190 (0.16%) than the resistance at $0.209 (10.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Matinas Biopharma Holdings Inc stock A Buy?

The Matinas Biopharma Holdings Inc stock holds several negative signals and despite the positive trend, we believe Matinas Biopharma Holdings Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.875 Sell Candidate Unchanged

Predicted Opening Price for Matinas Biopharma Holdings Inc of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$0.190 ( 0.246%) $0.190

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MTNB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.208 9.23 %
R2 0.201 5.61 %
R1 0.196 3.37 %
Current price: 0.190
Support S1 0.183 -3.86 %
S2 0.178 -6.10 %
S3 0.172 -9.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.228 19.74 %
R2 0.219 15.47 %
R1 0.209 10.00 %
Current price 0.190
Support S1 0.190 -0.158%
S2 0 .
S3 0 .

FAQ

What is the symbol for Matinas Biopharma Holdings Inc Stock and on which exchange is it traded?
The symbol for Matinas Biopharma Holdings Inc is MTNB and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Matinas Biopharma Holdings Inc Stock?
The Matinas Biopharma Holdings Inc stock holds several negative signals and despite the positive trend, we believe Matinas Biopharma Holdings Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Matinas Biopharma Holdings Inc Stock?
Matinas Biopharma Holdings Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Matinas Biopharma Holdings Inc Stock.

What's the current price of Matinas Biopharma Holdings Inc Stock?
As of the end of day on the 2024-04-18, the price of an Matinas Biopharma Holdings Inc (MTNB) share was $0.190.

What is the 52-week high and low for Matinas Biopharma Holdings Inc Stock?
The 52-week high for Matinas Biopharma Holdings Inc Stock is $0.88 and the 52-week low is $0.112.

What is the market capitalization of Matinas Biopharma Holdings Inc Stock?
As of the 2024-04-18, the market capitalization of Matinas Biopharma Holdings Inc is 47.655M.

When is the next earnings date for Matinas Biopharma Holdings Inc?
The upcoming earnings date for Matinas Biopharma Holdings Inc is May 08, 2024.
Click to get the best stock tips daily for free!

About Matinas Biopharma Holdings Inc

Matinas Biopharma Holdings Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a presc... MTNB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT